PUBLISHER: TechSci Research | PRODUCT CODE: 2048408
PUBLISHER: TechSci Research | PRODUCT CODE: 2048408
Peri-implantitis Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Non-Surgical, Surgical), By End-User (Dental Clinics, Hospitals), By Region & Competition, 2021-2031F
We offer 8 hour analyst time for an additional research. Please contact us for the details.
The Global Peri-implantitis Market is projected to grow substantially from USD 11,024.43 Million in 2025 to USD 17,679.86 Million by 2031, at an 8.19% Compound Annual Growth Rate. Peri-implantitis is a pathological inflammatory condition characterized by soft tissue inflammation and the progressive loss of supporting bone around a dental implant. The market's primary driver is the increasing global volume of dental implant procedures, fueled by an aging population and rising rates of edentulism. As the cumulative number of placed implants increases, the incidence of biological complications like peri-implantitis naturally rises, creating a sustained demand for diagnostic and therapeutic solutions. For example, approximately three million individuals in the United States had dental implants in 2025, according to the American Academy of Implant Dentistry, representing a significant patient pool susceptible to this disease.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 11,024.43 Million |
| Market Size 2031 | USD 17,679.86 Million |
| CAGR 2026-2031 | 8.19% |
| Fastest Growing Segment | Dental Clinics |
| Largest Market | North America |
Market Driver
The expanding volume of dental implant procedures serves as the main catalyst for the Global Peri-implantitis Market, as the rising count of placed implants directly correlates with a higher incidence of biological complications, thereby increasing the patient pool requiring therapeutic intervention. This trend is underscored by robust financial results from key industry players, signaling continued growth in implant therapy. Concurrently, technological advancements in regenerative and laser therapies are propelling market expansion by providing clinicians with more predictable and efficient protocols for biofilm decontamination and tissue preservation. Innovations such as electrolytic cleaning systems and advanced laser modalities are effectively overcoming limitations of mechanical debridement, thus encouraging higher treatment acceptance. The industry's commitment to standardizing these advanced interventions is further demonstrated by collaborative efforts to establish unified, evidence-based guidelines for managing peri-implant diseases.
Market Challenge
A significant challenge impeding market growth is the unpredictability of clinical outcomes associated with current regenerative treatments for peri-implantitis. The absence of a universally standardized protocol creates considerable uncertainty for dental professionals regarding the long-term success of preservation therapies. This lack of confidence often leads clinicians to opt for implant removal rather than investing in or recommending costly and uncertain preservation procedures, thereby suppressing the adoption of advanced market solutions. This clinical uncertainty, compounded by inconsistent insurance reimbursement for peri-implantitis management, frequently biases decision-making toward explantation as a more predictable and financially prudent alternative. This preference limits the revenue potential for diagnostic and regenerative products, even though clinical data from 2025 indicated peri-implantitis affected roughly 22% of patients with dental implants.
Market Trends
The Global Peri-implantitis Market is undergoing transformation driven by key trends, primarily the integration of Artificial Intelligence and digital imaging for early detection, which shifts clinical focus from reactive treatment to predictive monitoring. Cloud-native platforms and AI-driven diagnostics enable unprecedented precision in identifying initial bone loss and soft tissue anomalies, standardizing care and facilitating timely interventions before significant complications arise. This is supported by the rapid uptake of connected diagnostic ecosystems, as evidenced by Dentsply Sirona's DS Core digital platform exceeding 37,000 unique users. Simultaneously, strategic consolidation through mergers and acquisitions in dental care is establishing robust, vertically integrated networks that streamline the delivery of complex implant therapies. These consolidations aggregate implant systems, digital workflows, and consumables, enhancing operational efficiency, broadening market access, and fostering consistent procedural outcomes, thereby mitigating market fragmentation and solidifying the adoption of standardized implant solutions.
Key Market Players
- Straumann Group
- Dentsply Sirona Inc.
- Zimmer Biomet Holdings, Inc.
- Nobel Biocare Services AG
- Institut Straumann AG
- BioHorizons IPH, Inc.
- Keystone Dental, Inc.
- Thommen Medical AG
- Neoss Limited
- MegaGen Implant Co., Ltd.
Report Scope
In this report, the Global Peri-implantitis Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Peri-implantitis Market, By Type
- Non-Surgical
- Surgical
Peri-implantitis Market, By End-User
- Dental Clinics
- Hospitals
Peri-implantitis Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Peri-implantitis Market.
Available Customizations:
Global Peri-implantitis Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
- 1.1. Market Definition
- 1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations
2. Research Methodology
- 2.1. Objective of the Study
- 2.2. Baseline Methodology
- 2.3. Key Industry Partners
- 2.4. Major Association and Secondary Sources
- 2.5. Forecasting Methodology
- 2.6. Data Triangulation & Validation
- 2.7. Assumptions and Limitations
3. Executive Summary
- 3.1. Overview of the Market
- 3.2. Overview of Key Market Segmentations
- 3.3. Overview of Key Market Players
- 3.4. Overview of Key Regions/Countries
- 3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Peri-implantitis Market Outlook
- 5.1. Market Size & Forecast
- 5.1.1. By Value
- 5.2. Market Share & Forecast
- 5.2.1. By Type (Non-Surgical, Surgical)
- 5.2.2. By End-User (Dental Clinics, Hospitals)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
- 5.3. Market Map
6. North America Peri-implantitis Market Outlook
- 6.1. Market Size & Forecast
- 6.1.1. By Value
- 6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End-User
- 6.2.3. By Country
- 6.3. North America: Country Analysis
- 6.3.1. United States Peri-implantitis Market Outlook
- 6.3.1.1. Market Size & Forecast
- 6.3.1.1.1. By Value
- 6.3.1.2. Market Share & Forecast
- 6.3.1.2.1. By Type
- 6.3.1.2.2. By End-User
- 6.3.1.1. Market Size & Forecast
- 6.3.2. Canada Peri-implantitis Market Outlook
- 6.3.2.1. Market Size & Forecast
- 6.3.2.1.1. By Value
- 6.3.2.2. Market Share & Forecast
- 6.3.2.2.1. By Type
- 6.3.2.2.2. By End-User
- 6.3.2.1. Market Size & Forecast
- 6.3.3. Mexico Peri-implantitis Market Outlook
- 6.3.3.1. Market Size & Forecast
- 6.3.3.1.1. By Value
- 6.3.3.2. Market Share & Forecast
- 6.3.3.2.1. By Type
- 6.3.3.2.2. By End-User
- 6.3.3.1. Market Size & Forecast
- 6.3.1. United States Peri-implantitis Market Outlook
7. Europe Peri-implantitis Market Outlook
- 7.1. Market Size & Forecast
- 7.1.1. By Value
- 7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End-User
- 7.2.3. By Country
- 7.3. Europe: Country Analysis
- 7.3.1. Germany Peri-implantitis Market Outlook
- 7.3.1.1. Market Size & Forecast
- 7.3.1.1.1. By Value
- 7.3.1.2. Market Share & Forecast
- 7.3.1.2.1. By Type
- 7.3.1.2.2. By End-User
- 7.3.1.1. Market Size & Forecast
- 7.3.2. France Peri-implantitis Market Outlook
- 7.3.2.1. Market Size & Forecast
- 7.3.2.1.1. By Value
- 7.3.2.2. Market Share & Forecast
- 7.3.2.2.1. By Type
- 7.3.2.2.2. By End-User
- 7.3.2.1. Market Size & Forecast
- 7.3.3. United Kingdom Peri-implantitis Market Outlook
- 7.3.3.1. Market Size & Forecast
- 7.3.3.1.1. By Value
- 7.3.3.2. Market Share & Forecast
- 7.3.3.2.1. By Type
- 7.3.3.2.2. By End-User
- 7.3.3.1. Market Size & Forecast
- 7.3.4. Italy Peri-implantitis Market Outlook
- 7.3.4.1. Market Size & Forecast
- 7.3.4.1.1. By Value
- 7.3.4.2. Market Share & Forecast
- 7.3.4.2.1. By Type
- 7.3.4.2.2. By End-User
- 7.3.4.1. Market Size & Forecast
- 7.3.5. Spain Peri-implantitis Market Outlook
- 7.3.5.1. Market Size & Forecast
- 7.3.5.1.1. By Value
- 7.3.5.2. Market Share & Forecast
- 7.3.5.2.1. By Type
- 7.3.5.2.2. By End-User
- 7.3.5.1. Market Size & Forecast
- 7.3.1. Germany Peri-implantitis Market Outlook
8. Asia Pacific Peri-implantitis Market Outlook
- 8.1. Market Size & Forecast
- 8.1.1. By Value
- 8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End-User
- 8.2.3. By Country
- 8.3. Asia Pacific: Country Analysis
- 8.3.1. China Peri-implantitis Market Outlook
- 8.3.1.1. Market Size & Forecast
- 8.3.1.1.1. By Value
- 8.3.1.2. Market Share & Forecast
- 8.3.1.2.1. By Type
- 8.3.1.2.2. By End-User
- 8.3.1.1. Market Size & Forecast
- 8.3.2. India Peri-implantitis Market Outlook
- 8.3.2.1. Market Size & Forecast
- 8.3.2.1.1. By Value
- 8.3.2.2. Market Share & Forecast
- 8.3.2.2.1. By Type
- 8.3.2.2.2. By End-User
- 8.3.2.1. Market Size & Forecast
- 8.3.3. Japan Peri-implantitis Market Outlook
- 8.3.3.1. Market Size & Forecast
- 8.3.3.1.1. By Value
- 8.3.3.2. Market Share & Forecast
- 8.3.3.2.1. By Type
- 8.3.3.2.2. By End-User
- 8.3.3.1. Market Size & Forecast
- 8.3.4. South Korea Peri-implantitis Market Outlook
- 8.3.4.1. Market Size & Forecast
- 8.3.4.1.1. By Value
- 8.3.4.2. Market Share & Forecast
- 8.3.4.2.1. By Type
- 8.3.4.2.2. By End-User
- 8.3.4.1. Market Size & Forecast
- 8.3.5. Australia Peri-implantitis Market Outlook
- 8.3.5.1. Market Size & Forecast
- 8.3.5.1.1. By Value
- 8.3.5.2. Market Share & Forecast
- 8.3.5.2.1. By Type
- 8.3.5.2.2. By End-User
- 8.3.5.1. Market Size & Forecast
- 8.3.1. China Peri-implantitis Market Outlook
9. Middle East & Africa Peri-implantitis Market Outlook
- 9.1. Market Size & Forecast
- 9.1.1. By Value
- 9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End-User
- 9.2.3. By Country
- 9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Peri-implantitis Market Outlook
- 9.3.1.1. Market Size & Forecast
- 9.3.1.1.1. By Value
- 9.3.1.2. Market Share & Forecast
- 9.3.1.2.1. By Type
- 9.3.1.2.2. By End-User
- 9.3.1.1. Market Size & Forecast
- 9.3.2. UAE Peri-implantitis Market Outlook
- 9.3.2.1. Market Size & Forecast
- 9.3.2.1.1. By Value
- 9.3.2.2. Market Share & Forecast
- 9.3.2.2.1. By Type
- 9.3.2.2.2. By End-User
- 9.3.2.1. Market Size & Forecast
- 9.3.3. South Africa Peri-implantitis Market Outlook
- 9.3.3.1. Market Size & Forecast
- 9.3.3.1.1. By Value
- 9.3.3.2. Market Share & Forecast
- 9.3.3.2.1. By Type
- 9.3.3.2.2. By End-User
- 9.3.3.1. Market Size & Forecast
- 9.3.1. Saudi Arabia Peri-implantitis Market Outlook
10. South America Peri-implantitis Market Outlook
- 10.1. Market Size & Forecast
- 10.1.1. By Value
- 10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By End-User
- 10.2.3. By Country
- 10.3. South America: Country Analysis
- 10.3.1. Brazil Peri-implantitis Market Outlook
- 10.3.1.1. Market Size & Forecast
- 10.3.1.1.1. By Value
- 10.3.1.2. Market Share & Forecast
- 10.3.1.2.1. By Type
- 10.3.1.2.2. By End-User
- 10.3.1.1. Market Size & Forecast
- 10.3.2. Colombia Peri-implantitis Market Outlook
- 10.3.2.1. Market Size & Forecast
- 10.3.2.1.1. By Value
- 10.3.2.2. Market Share & Forecast
- 10.3.2.2.1. By Type
- 10.3.2.2.2. By End-User
- 10.3.2.1. Market Size & Forecast
- 10.3.3. Argentina Peri-implantitis Market Outlook
- 10.3.3.1. Market Size & Forecast
- 10.3.3.1.1. By Value
- 10.3.3.2. Market Share & Forecast
- 10.3.3.2.1. By Type
- 10.3.3.2.2. By End-User
- 10.3.3.1. Market Size & Forecast
- 10.3.1. Brazil Peri-implantitis Market Outlook
11. Market Dynamics
- 11.1. Drivers
- 11.2. Challenges
12. Market Trends & Developments
- 12.1. Merger & Acquisition (If Any)
- 12.2. Product Launches (If Any)
- 12.3. Recent Developments
13. Global Peri-implantitis Market: SWOT Analysis
14. Porter's Five Forces Analysis
- 14.1. Competition in the Industry
- 14.2. Potential of New Entrants
- 14.3. Power of Suppliers
- 14.4. Power of Customers
- 14.5. Threat of Substitute Products
15. Competitive Landscape
- 15.1. Straumann Group
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
- 15.2. Dentsply Sirona Inc.
- 15.3. Zimmer Biomet Holdings, Inc.
- 15.4. Nobel Biocare Services AG
- 15.5. Institut Straumann AG
- 15.6. BioHorizons IPH, Inc.
- 15.7. Keystone Dental, Inc.
- 15.8. Thommen Medical AG
- 15.9. Neoss Limited
- 15.10. MegaGen Implant Co., Ltd.
16. Strategic Recommendations
17. About Us & Disclaimer
